Is Medtronic PLC (MDT) Stock Over or Undervalued?

InvestorsObserver gives Medtronic PLC (MDT) a weak valuation score of 28 from its analysis. The proprietary scoring system considers the underlying health of a company by analyzing its stock price, earnings, and growth rate. MDT currently holds a better value than 28% of stocks based on these metrics. Long term investors focused on buying-and-holding should find the valuation ranking system most relevant when making investment decisions.

MDT gets a 28 Valuation Rank today. Find out what this means to you and get the rest of the rankings on MDT!

See Full MDT Report

Metrics Analysis

MDT has a trailing twelve month Price to Earnings (PE) ratio of 26.31. The historical average of roughly 15 shows a poor value for MDT stock as investors are paying higher share prices relative to the company's earnings. MDT's high trailing PE ratio shows that the firm has been trading above its fair market value recently. Its trailing 12-month earnings per share (EPS) of 3.15 does not justify the stock's current price. However, trailing PE ratios do not factor in the company's projected growth rate, resulting in many newer firms having high PE ratios due to high growth potential enticing investors despite inadequate earnings. MDT has a 12 month forward PE to Growth (PEG) ratio of 2.84. Markets are overvaluing MDT in relation to its projected growth as its PEG ratio is currently above the fair market value of 1. 3.15's PEG comes from its forward price to earnings ratio being divided by its growth rate. PEG ratios are one of the most used valuation metrics due to its incorporation of more company fundamentals metrics and a focus on the firm's future rather than its past.

Summary

MDT' has a weak valuation at its current share price on account of a overvalued PEG ratio due to strong growth. MDT's PE and PEG are worse than the market average leading to a below average valuation score. Click Here to get the full Report on Medtronic PLC (MDT) stock.